Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 1999Current Opinion in Clinical Nutrition & Metabolic Care

Lipid treatment of inflammatory bowel disease

View Full Paper
Ask AI
Bookmark
Share

Authors

SEStefan EndresLMU KlinikumRLReinhard LorenzInstitute for Sports MedicineKLK. LoeschkeShowa University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Endres et al. (1999) studied this question.

synapsesocial.com/papers/6a92f379e7c653de188eff8dhttps://doi.org/10.1097/00075197-199903000-00004
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.1989 · 440 citations
  2. 2Dietary Supplementation with Fish Oil in Ulcerative Colitis1992 · 398 citations
  3. 3Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.1990 · 404 citations
  4. 4The Effect of Dietary Supplementation with n—3 Polyunsaturated Fatty Acids on the Synthesis of Interleukin-1 and Tumor Necrosis Factor by Mononuclear Cells1989 · 1,924 citations
  5. 5Treatment of Ulcerative Colitis with Fish Oil n-3-ω-Fatty Acid1990 · 137 citations